UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549



                                  SCHEDULE 13G



                    Under the Securities Exchange Act of 1934

                                (Amendment No. )*


                                 UROPLASTY, INC.
                                (Name of Issuer)


                                  COMMON STOCK
                         (Title of Class of Securities)


                                    917277204
                                 (CUSIP Number)


                                  July 31, 2002
             (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

         [X]  Rule 13d-1(b)
         [_]  Rule 13d-1(c)
         [_]  Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

                                Page 1 of 6 pages



CUSIP No. 917277204                     13G                    Page 2 of 6 Pages



1.  NAME OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS

                 HEARTLAND ADVISORS, INC.

                 #39-1078128

2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                               (a)  [_]
                                               (b)  [_]

3.  SEC USE ONLY

4.  CITIZENSHIP OR PLACE OF ORGANIZATION

                 WISCONSIN, U.S.A.

          NUMBER OF            5.  SOLE VOTING POWER
           SHARES
        BENEFICIALLY               None
          OWNED BY
            EACH               6.  SHARED VOTING POWER
         REPORTING
           PERSON                  None
            WITH
                               7.  SOLE DISPOSITIVE POWER

                                   377,500

                               8.  SHARED DISPOSITIVE POWER

                                   None

9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

         377,500

10.  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES



11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

         8.5%

12.  TYPE OF REPORTING PERSON

                 IA



CUSIP No. 917277204                   13G                      Page 3 of 6 Pages



1.  NAME OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS

                  WILLIAM J. NASGOVITZ           395-42-0703


2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                               (a)  [_]
                                               (b)  [_]

3.  SEC USE ONLY

4.  CITIZENSHIP OR PLACE OF ORGANIZATION

                  WISCONSIN, U.S.A.

          NUMBER OF            5.  SOLE VOTING POWER
           SHARES
        BENEFICIALLY               None
          OWNED BY
            EACH               6.  SHARED VOTING POWER
         REPORTING
           PERSON                  None
            WITH
                               7.  SOLE DISPOSITIVE POWER

                                   None

                               8.  SHARED DISPOSITIVE POWER

                                   None

9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

         None

10.  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES



11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

         0.0%

12.  TYPE OF REPORTING PERSON

                  IN



CUSIP No. 917277204                 13G                        Page 4 of 6 Pages

Item 1.
      (a) Name of Issuer:   Uroplasty, Inc.
          --------------


      (b) Address of Issuer's Principal Executive Offices:
          -----------------------------------------------
             2718 Summer Street NE
             Minneapolis, MN 55413-2820

Item 2.
      (a) Name of Person Filing:
          ---------------------
          (1) Heartland Advisors, Inc.
          (2) William J. Nasgovitz

      (b) Address of Principal Business Office:
          ------------------------------------
          (1) 789 North Water Street
              Milwaukee, WI  53202

          (2) 789 North Water Street
              Milwaukee, WI 53202

      (c) Citizenship:  Heartland Advisors is a Wisconsin corporation.
          -----------
                        William J. Nasgovitz - U.S.A.

      (d) Title of Class of Securities:  Common Stock
          ----------------------------

      (e) CUSIP Number:  917277204
          ------------

Item 3. The persons filing this Schedule 13G are Heartland Advisors, Inc., an
investment adviser registered with the SEC, and William J. Nasgovitz, President
and principal shareholder of Heartland Advisors, Inc. Mr. Nasgovitz joins in
this filing pursuant to SEC staff positions authorizing certain individuals in
similar situations to join in a filing with a controlled entity eligible to file
on Schedule 13G. The reporting persons do not admit that they constitute a
group.

Item 4. Ownership.
        ---------

      (a) Amount beneficially owned:
          --------------------------

          377,500 shares may be deemed beneficially owned within the meaning of
Rule 13d-3 of the Securities Exchange Act of 1934 by (1) Heartland Advisors,
Inc. by virtue of its investment discretion over client securities, which may be
revoked; and (2) William J. Nasgovitz, as a result of his position with and
stock ownership of Heartland which could be deemed to confer upon him investment
power over the shares Heartland beneficially owns.

      (b) Percent of Class:
          -----------------
          8.5%

      (c) For information on voting and dispositive power with respect to the
above listed shares, see Items 5-8 of the Cover Page.



CUSIP No. 917277204                   13G                      Page 5 of 6 Pages


Item 5. Ownership of Five Percent or Less of a Class.
        --------------------------------------------

        If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following:[ ]

Item 6. Ownership of more than Five Percent on Behalf of Another Person.
        ----------------------------------------------------------------

        The shares of common stock to which this Schedule relates represent more
than 5% of the class and are held in an investment advisory account of Heartland
Advisors, Inc. for the benefit of Turn of the Tide, a Wisconsin Limited
Partnership. As a result, various persons have the right to receive or the power
to direct the receipt of dividends from, or the proceeds from the sale of, the
securities.

Item 7. Identification and Classification of the Subsidiary Which Acquired the
        ----------------------------------------------------------------------
        Security Being Reported on By the Parent Holding Company.
        ---------------------------------------------------------

        Not Applicable.

Item 8. Identification and Classification of Members of the Group.
        ---------------------------------------------------------

        Not Applicable.

Item 9. Notice of Dissolution of Group.
        ------------------------------

        Not Applicable.

Item 10.  Certification.
          -------------

        By signing below, the undersigned certify that, to the best of their
knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.

                                    SIGNATURE

           After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.

DATE: August 9, 2002

WILLIAM J. NASGOVITZ                        HEARTLAND ADVISORS, INC.

By: /s/ PAUL T. BESTE                       By: /s/ PAUL T. BESTE
---------------------                               -------------
    Paul T. Beste                                   Paul T. Beste
    As Attorney in Fact for                         Chief Operating Officer
    William J. Nasgovitz

EXHIBIT INDEX

        Exhibit 1    Joint Filing Agreement



EXHIBIT 1


                             Joint Filing Agreement


The undersigned persons agree and consent to the joint filing on their behalf of
this Schedule 13G in connection with their beneficial ownership of UROPLASTY,
Inc. at July 31, 2002.

WILLIAM J. NASGOVITZ

By: /s/ PAUL T. BESTE
        -------------
        Paul T. Beste
        As Attorney in Fact for William J. Nasgovitz




HEARTLAND ADVISORS, INC.


By: /s/ PAUL T. BESTE
        -------------
        Paul T. Beste
        Chief Operating Officer